Product Images Brinzolamide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Brinzolamide NDC 0591-2127 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
formula - image 1
1 - image 2
Brinzolamide Ophthalmic Suspension, USP is a medication that is to be used for topical ophthalmic use only. It is an ophthalmic solution designed for the treatment of ocular hypertension and glaucoma. The medication is to be used with caution and must not be touched to any surface as it can contaminate the solution. The text also mentions that Brinzolamide Ophthalmic Suspension, USP must be shaken well before use. The usual dosage is one drop in the affected eye(s) three times daily. The suspension is manufactured in India by Indoco Ret, Verna Goa-403722, and is distributed in the US by Teva Pharmaceuticals USA, Parsippany, 07054. The main components of this suspension include Brinzolamide USP (10mg), BAK 0.1%, Carbomer 974P, Mannitol, and Edetate Disodium.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.